News
Market and company headlines
Wall Street analysts adjusted price targets for CDNS, FN, SAM, BOH, FLEX, AGYS and FDX; BOH was downgraded to Market Perform.

Morgan Stanley analyst Erin Wright maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price target from $529 to $531.

Key TakeawaysUnitedHealth shares rose 3. 5% today after RBC Capital raised its price target to $498 from $478, and other managed care stocks rose with it.

Key TakeawaysUnitedHealth stock is up 11% in the past week (through Tuesday’s close), after a third-quarter beat and a raised 2026 outlook for adjusted EPS of at least $20. 50.

Key TakeawaysUnitedHealth’s adjusted EPS jumped 61% to $4. 69, beating the $4.

UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Mizuho analyst Ann Hynes maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $493 to $500.

UnitedHealth Group (NYSE:UNH) and Humana outlined 2027 Medicare plan adjustments that raise premiums and out of pocket costs for seniors. The insurers also flagged cuts to certain Medicare benefits from 2027, affecting coverage breadth and plan value for enrolled beneficiaries. UnitedHealth publicly objected to its shares being offered as tokenized stock on the OKXICE trading platform, challenging the listing. These 2027 Medicare changes and UnitedHealth's stance on OKXICE tokenized trading...
UnitedHealth's third-quarter results beat estimates and lifted its outlook. Can tighter cost control and an Optum rebound keep the recovery going?

UnitedHealth Group Incorporated (NYSE:UNH) produced $8.0 billion of second-quarter 2026 operating earnings, with Optum contributing $4.0 billion. Medical inflation and Medicare funding pressure reach both insurance and care delivery, however. The investment question is how much profit survives when treating patients becomes more expensive. A forward P/E around 17x looks fairly valued for UnitedHealth Group […]
Dow Jones top gainers for the Oct. 20, 2026 US session included MMM, UNH, MRK, JNJ, and AMGN, with the article noting their gains and longer-term performance.

UnitedHealth Strong Buy: $533 target with 33% upside. Click here to read my most recent analysis of UNH stock.

UnitedHealth, ServiceNow, 3M and Coffee Holding draw attention as new research reports weigh growth drivers, operational strengths and risks across healthcare, software, industry and coffee.

RBC Capital analyst Ben Hendrix maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $478 to $498.

UnitedHealth, ServiceNow and 3M feature in today's top research reports, with AI-driven growth, operational gains and cost pressures shaping their outlooks.

UnitedHealth Group (UNH) raised its 2026 earnings outlook after reporting third quarter results that exceeded expectations, drawing fresh analyst attention and renewed interest from investors watching medical cost trends. UnitedHealth Group's 1-month share price return of 6.51% and 7-day gain of 6.05% reflect renewed momentum after its earnings beat and raised 2026 outlook, even though the stock is still down 8% over 90 days and its 3-year total shareholder return has declined 18.04%. Scan...
The Investment Committee gives you its top stocks to watch for the second half.

UnitedHealth Group (UNH) stock trades at 25.6 times its earnings over the last twelve months. That valuation represents a premium against 22.9 for the S&P 500, suggesting investors are betting on a profit recovery. On October 13, 2026, the company raised its guidance for the full year. During the earnings call that day, executives warned that cost trends for commercial benefits are exceeding initial expectations of 11%. They cited high-cost specialty drugs and the No Surprises Act. So how much p
UnitedHealth's Q3 earnings beat estimates, lifting shares 6.3%. Explore three healthcare ETFs offering UNH exposure while diversifying Medicaid risks.

UnitedHealth Group's Q3 earnings beat estimates, with revenue of $112.7B and EPS of $4.69. Find out why UNH stock is downgraded from Strong Buy to Buy.

UnitedHealth (UNH) Q3 results beat as guidance rises. Learn more.

UNH's Q3 earnings surge and improving margins signal a recovery, but falling membership and elevated utilization raise questions about sustained growth.

UnitedHealth Group (UNH) could find its next growth engine in the care it delivers. That perspective carries weight right now. During the company's October 13 call, management raised its 2026 outlook to adjusted earnings per share of at least $20.50. Yet executives also warned that medical costs remain stubbornly high across health care. So which part of UnitedHealth's care business still has room to grow.

Bernstein analyst Lance Wilkes maintains UnitedHealth Group (NYSE:UNH) with a Outperform and lowers the price target from $512 to $500.
JP Morgan analyst Lisa Gill maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price target from $516 to $524.

UnitedHealth Group reported third quarter 2026 revenue of US$112.7b with net income of US$4.1b and raised full year 2026 earnings guidance to at least US$19.50 in diluted EPS and more than US$17.65b in net earnings attributable to common shareholders. Alongside the stronger profit picture, UnitedHealth Group continued its long running buyback program, retiring about 3.5m shares in the latest quarter and bringing cumulative repurchases to roughly 737m shares since 2006. This reduces the share...
UnitedHealth's wild ride inside DIA was not an accident or a manager's call. The weighting rule baked into the Dow determined exactly how much of your money followed the stock up and down, and most investors have never read that single line in the prospectus.

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 20 years by 2.07% on an annualized basis producing an average annual return of 11.07%. Currently, UnitedHealth Group has a market capitalization of

UnitedHealth's focus on special needs plans, expanded Medicare coverage and improved margins could drive targeted growth in 2027 despite cost challenges.

UnitedHealth Group Inc. (NYSE: UNH) shares are climbing Thursday as analysts react to a strong third-quarter report and raised 2026 guidance.

Friday’s gain suggests investors are treating the ratings as a 2028 problem. Tuesday’s call gives management an opportunity to clarify how many members are in downgraded plans and discuss the potential financial impact.

UnitedHealth Group (UNH) reached $378.81 at the closing of the latest trading day, reflecting a +2.12% change compared to its last close.

The investment case for UnitedHealth Group Inc. (NYSE:UNH) rests on how management can restore the company’s profitability margins and reignite its topline expansion to justify an earnings turnaround, which the current forward P/E multiple already assumes. The overall profile for UnitedHealth appears mixed yet highly intriguing. Despite its cash flow strength, flat revenue growth and […]

A single Medicare quality ratings release sent one major insurer soaring while dragging a rival into the red, and the gap between winners and losers points to something deeper than a routine scoring update.
UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.

The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-investigates-unitedhealth-group-denying-patients-coverage-they-need-and

UnitedHealth Group (UNH) remains a Buy, with fundamentals improving and valuation at a decade low P/E of 19.95 despite peer discounts.

UnitedHealthcare and Aetna plan tighter Medicare Advantage networks by 2027 as costs rise, while premiums fall.

UnitedHealth Group (UNH) is back in focus after the stock recently outperformed major indexes as investors weigh the company’s expanded 2027 Medicare Advantage lineup and earnings expectations ahead of its October 13 report. Recent trading tells a mixed story. UnitedHealth Group’s share price is up 10.55% year to date, yet the 30 day share price return is down 6.36% and the 90 day share price return is down 11.03%. At the same time, the 3 year total shareholder return is down 24.54%,...

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $371.9, denoting a +1.83% move from the preceding trading day.

Key Stats for UnitedHealth StockCurrent Price: $365. 20Target Price (Mid): ~$586Street Target: ~$482Potential Total Return: ~61%Annualized IRR: ~12% / yearWhat Happened?UnitedHealth Group (UNH:NYSE) is shutting Medicare Advantage plans that cover about 390,000 people for 2027, a company spokesperson told Bloomberg on October 1.
October 01, 2026--UnitedHealthcare today introduced its 2027 Medicare Advantage plans, designed to bring affordability, simplicity and a more connected care experience to a growing and increasingly diverse population of beneficiaries. As America’s most chosen Medicare brand for 18 years in a row1, the company's Medicare portfolio continues to focus on delivering the benefits members value most while advancing new ways to make healthcare more accessible, personalized and easier to use.
UnitedHealthcare unveils 2027 Medicare Advantage plans with lower costs, $0 premiums, and updated UCard perks amid lawsuit fallout.

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $367.08, denoting a -2.1% move from the preceding trading day.

A federal judge in Minnesota granted in part and denied in part UnitedHealth's (UNH) motion to dismi

Her surgeon is scheduled, her prior authorization is approved, and her surgery date is locked in for January. What her insurer has not told her could unravel all three.
UnitedHealth Group (NYSE:UNH) has appointed Robert Hunter as president of UnitedHealthcare as part of a leadership realignment. The new UnitedHealthcare chief is expected to help advance a multi-year plan focused on margin recovery and modernization of operations. Hunter’s remit includes restoring confidence among regulators and customers while sharpening the business’s digital experience across key insurance offerings. The Robert Hunter appointment at UnitedHealthcare is important, but...

UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.

ACHC shares have doubled YTD as a raised 2026 outlook, stronger cash flow and new facility openings bolster its rebound.







